The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances. Talk of testosterone deficiency is hard to escape these days, with podcasters and politicians obsessing over how to avoid a "low T" lifestyle. As the hormone's cultural salience deepens, demand is growing. In a timely move, telehealth giant Hims just launched a testosterone replacement therapy service for cisgender men. The direct-to-consumer juggernaut will offer two types of injectable treatments, as well as an oral pill option that can be sent to patients after they take an at-home capillary blood test.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

Say More Versus Trending Now Look Up In My Bag Mashable's Best: E-readers, robovacs, laptops, earbuds, smart home and more Mashable @Home Mashable Selects Top creators, ranked Gift Ideas For Everyone On Your List Creator Playbook AI at School All Series Influencers are shilling libido products. Which ones should you use? Experts break down what's worth your time and money. Anna Iovine is the associate editor of features at Mashable. Previously, as the sex and relationships reporter, she covered topics ranging from dating apps to pelvic pain. Before Mashable, Anna was a social editor at VICE and freelanced for publications such as Slate and the Columbia Journalism Review.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

Journalist hilariously fails claiming WNBA's popularity isn't affected by Caitlin Clark's playoff exit Cooper Gallant slept in his truck for years chasing pro fishing dream: 'I didn't have a Plan B' Deion Sanders dared the media to write the truth about Colorado football: Ok, it's time to end this charade Madison Beer is being accused of ruining Justin Herbert's career, sad Eagles fans & Yankees fans fighting Bears' Devin Bush says win over Jets was'probably one of the easiest NFL games I have played in' WWE great Diamond Dallas Page'would love to see' LA Knight capture title vs Roman Reigns at Money in the Bank Jack Smith wears'No Kings' shirt just days after Trump hearing This man was radicalized by the Taliban. Art Laffer on socialism threat: 'I don't think these guys are serious' Ken Griffin's $3 BILLION donation sparks NYC vs Miami debate We've seen this playbook before, Gen. Keane says The all-time goal-scoring leader with 929 goals shared his decision ahead of the Capitals' home opener against Pittsburgh Well, it's great that he apologized. Who exactly is he apologizing to? Alex Ovechkin announced on Monday ahead of the Washington Capitals home opener against the Pittsburgh Penguins that this season will be his last in the National Hockey League. The 41-year-old signed a one-year contract during the offseason to return to Washington for what is his 22nd season in the NHL, all of which he has spent in the nation's capital.

The device made by Flow Neuroscience is approved by the FDA and could help people get off antidepressants--but it costs $2,200. An at-home wearable for the treatment of depression is now available by prescription in the US. With roughly one in six American adults taking an antidepressant medication, Swedish firm Flow Neuroscience is positioning its device as an alternative to traditional drugs. But at the current four-figure price tag, it might take a while for the futuristic-looking headset to catch on with patients. Worn on the forehead for 30 minutes a day and operated with an app, the device provides low-intensity electrical stimulation to the left frontal lobe of the brain, an area involved in regulating mood and emotions.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

Good Connection: Uplifting stories for a digital age Creator Playbook Trending Now Say More Look Up Mashable's Best: E-readers, robovacs, laptops, earbuds, smart home and more Switch Off Mashable Voices Mashable Selects Safety Net Versus Gift Ideas For Everyone On Your List All Series'I get so upset and frustrated': What dating is like on a GLP-1 Finding a partner after weight loss might be even harder. Anna Iovine is the associate editor of features at Mashable. Previously, as the sex and relationships reporter, she covered topics ranging from dating apps to pelvic pain. Before Mashable, Anna was a social editor at VICE and freelanced for publications such as Slate and the Columbia Journalism Review. Follow her on Bluesky .

How an alliance of tech startups, MAHA operatives, and actual medical experts made millennial women the new face of hormone therapy. Lisa Schrenk didn't know it yet, as she trudged down a dirt trail last August, but her life was about to change. She'd set out late the night before with her hiking group, scrambling up Virginia's Old Rag Mountain in darkness. They reached the peak in time to watch the sun rise over the Blue Ridge range. Afterward, the women snapped photos. In one, Schrenk gazes out over the horizon, her long dark hair pulled into a ponytail. The image is deceptively triumphant. In reality, she had been contemplating suicide. Schrenk, a longtime IT specialist for the federal government, had started setting aside belongings for friends and family, organizing her financial affairs, and clearing out her office.

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this author to personalize your feed and get instant alerts.